Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Scintiscans and carcinoid tumors

B Carnaille1, M Nocaudie, F Pattou

  • 1Department of General and Endocrine Surgery, University Hospital, Lille, France.

Surgery
|December 1, 1994
PubMed
Summary

Somatostatin analog scans effectively image carcinoid tumors and metastases, aiding treatment decisions. Indium pentetreotide scans showed slightly better results than iodine octreotide for carcinoid imaging.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Pheochromocytomas and paragangliomas in pregnancy: About four cases and key messages on management].

Gynecologie, obstetrique, fertilite & senologie·2021
Same author

A new pharmacokinetic model for <sup>90</sup>Y-ibritumomab tiuxetan based on 3-dimensional dosimetry.

Scientific reports·2018
Same author

[Usefulness of nuclear medicine in Erdheim-Chester disease: A Lille experience].

La Revue de medecine interne·2017
Same author

Long term use of metformin in idiopathic cyclic edema, report of thirteen cases and review of the literature.

Pharmacological research·2017
Same author

Radioimmunotherapy ((90) Y-Ibritumomab Tiuxetan) for Posttransplant Lymphoproliferative Disorders After Prior Exposure to Rituximab.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

The coronary artery disease-associated gene C6ORF105 is expressed in human macrophages under the transcriptional control of PPARγ.

FEBS letters·2015

Area of Science:

  • Nuclear medicine
  • Oncology
  • Endocrinology

Background:

  • Somatostatin receptors on carcinoid tumors are key targets for imaging and therapy.
  • Radiolabeled somatostatin analogs offer potential for visualizing tumor extent and inhibiting growth.
  • This study evaluated the role of these analogs in the management of carcinoid tumors.

Purpose of the Study:

  • To assess the efficacy of radiolabeled somatostatin analog scans (iodine octreotide, indium pentetreotide) in the therapeutic workup of carcinoid tumors.
  • To compare the diagnostic performance of these scans with functional inhibition tests and metaiodobenzylguanidine (MIBG) scans.
  • To determine the utility of these imaging modalities in identifying tumor sites and metastases.

Main Methods:

  • Prospective evaluation of 26 scans in 21 patients with carcinoid tumors.

Related Experiment Videos

  • Utilized iodine octreotide and indium pentetreotide for imaging.
  • Compared scan results with marker secretion inhibition tests and MIBG scans.

    • Main Results:

    • Somatostatin analog scans achieved 72% sensitivity in imaging 43 tumor sites with no false positives.
    • Indium pentetreotide demonstrated slightly superior performance for metastases imaging.
    • Scans identified previously unknown tumor sites in three patients.
    • Results indicated somatostatin analog scans outperformed MIBG scans, with complementarity observed in one case.

    Conclusions:

    • Functional inhibition tests with octreotide, alongside indium pentetreotide and MIBG scans, are valuable for guiding carcinoid tumor treatment.
    • Somatostatin analog imaging provides crucial information for therapeutic planning in carcinoid patients.
    • The combination of imaging and functional tests enhances the comprehensive management of carcinoid disease.